Historical record - last NADAC publication: 5/22/2024

Product Information

CARDIZEM LA 180 MG TABLET is a brand product labeled by Bausch Health US LLC, priced at $3.8314 per EA under NDC 00187204630. Its NADAC has been published 137 times since Sep 10, 2014.

The High Outlier badge above means this manufacturer's average price in the Diltiazem Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CARDIZEM LA 180 MG TABLET

Diltiazem Hydrochloride
$3.8314per EA
High Outlier

Strength

180 mg/1

NDC

00187204630

Classification

Brand

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

5/22/2024

Active Ingredients

DILTIAZEM HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA021392

On Market Since

12/25/2010

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A4 Inhibitors

Price Statistics

The NADAC for CARDIZEM LA 180 MG TABLET has been published 137 times since Sep 10, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$3.8314 per EA
All-time high$3.9664 (Mar 16, 2016)
All-time low$3.8095 (Nov 19, 2014)
Median price$3.8314
Average price$3.8902
Largest weekly change+4.1% (Feb 18, 2015)
Weeks tracked137
Tracking sinceSep 10, 2014

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-3.4%

5Y

-3.4%

All

-1.7%

Generic Alternatives

The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CARDIZEM LA 180 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARDIZEM LA 180 MG TABLET, manufactured by Bausch Health US LLC, is $3.8314 per EA (NDC 00187204630), effective May 14, 2025.

How has the price of CARDIZEM LA 180 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARDIZEM LA 180 MG TABLET has held within roughly two percent of its current level. It has been tracked across 137 weekly CMS publications since Sep 10, 2014.

What are the highest and lowest recorded NADAC prices for CARDIZEM LA 180 MG TABLET?

Since Sep 10, 2014, the NADAC for CARDIZEM LA 180 MG TABLET has ranged from a low of $3.8095 (Nov 19, 2014) to a high of $3.9664 (Mar 16, 2016), with a median of $3.8314 per EA.

Are there cheaper alternatives to CARDIZEM LA 180 MG TABLET?

Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DILTIAZEM 24HR ER 180 MG CAP, is $0.1160 per EA — about 97% below CARDIZEM LA 180 MG TABLET.

Who manufactures CARDIZEM LA 180 MG TABLET?

CARDIZEM LA 180 MG TABLET (NDC 00187204630) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.